SLC25A4 and pulmonary fibrosis: ANT1 mutations, in particular, result in a number of diseases including hypertrophic cardiomyopathy, ophthalmoplegia, muscular dystrophy, bipolar disorder, and lung fibrosis (Mishra et al. 2023).